Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/11 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 144
- 較 2021 年第 3 季 +4
- 總值
- $34.0 億
- 較 2021 年第 3 季 −$6.64 億 (−16.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $2.80 億 | 8.2% | 00.0% | 不變 | 歷史 |
| WWWW International, Inc. | COM | 14,818,300 | $2.39 億 | 7.0% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,400,000 | $2.05 億 | 6.0% | +200,000+16.7% | 加碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 675,000 | $1.83 億 | 5.4% | +25,000+3.8% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 500,000 | $1.75 億 | 5.1% | −77,308−13.4% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 650,000 | $1.10 億 | 3.2% | −50,000−7.1% | 減碼 | 歷史 |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $1.08 億 | 3.2% | 00.0% | 不變 | 歷史 |
| FATEFate Therapeutics Inc | COM | 1,800,000 | $1.05 億 | 3.1% | +350,000+24.1% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 500,000 | $7,730 萬 | 2.3% | +125,000+33.3% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 1,585,049 | $7,510 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 6,000,000 | $6,930 萬 | 2.0% | −696,955−10.4% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 8,500,000 | $6,843 萬 | 2.0% | +3,250,000+61.9% | 加碼 | – |
| KYMRKymera Therapeutics, Inc. | COM | 1,000,000 | $6,349 萬 | 1.9% | +600,000+150.0% | 加碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 2,450,000 | $6,086 萬 | 1.8% | +500,000+25.6% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 850,000 | $5,268 萬 | 1.5% | +250,000+41.7% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 3,172,221 | $4,942 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 700,000 | $4,897 萬 | 1.4% | +200,000+40.0% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,500,000 | $4,863 萬 | 1.4% | −300,000−16.7% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $4,558 萬 | 1.3% | −300,000−23.1% | 減碼 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 1,500,000 | $4,400 萬 | 1.3% | +150,000+11.1% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,250,000 | $4,275 萬 | 1.3% | −250,000−16.7% | 減碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $4,254 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $4,028 萬 | 1.2% | +25,000+3.0% | 加碼 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $3,935 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| RUBYRubius Therapeutics, Inc. | COM | 3,701,580 | $3,583 萬 | 1.1% | −454,045−10.9% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $3,252 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $3,156 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $3,006 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $2,730 萬 | 0.8% | +1,149,425 | 新進 | 歷史 |
| EQRXEQRx, Inc. | COM | 4,000,000 | $2,728 萬 | 0.8% | +4,000,000 | 新進 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $2,676 萬 | 0.8% | +100,000+20.0% | 加碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $2,668 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $2,576 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 544,047 | $2,533 萬 | 0.7% | −450,000−45.3% | 減碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 900,000 | $2,439 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 700,000 | $2,438 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $2,364 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2,364 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 750,000 | $2,303 萬 | 0.7% | +350,000+87.5% | 加碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $2,287 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $2,097 萬 | 0.6% | +225,000+17.1% | 加碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 6,500,000 | $2,093 萬 | 0.6% | +1,000,000+18.2% | 加碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $1,992 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $1,944 萬 | 0.6% | +1,302,291+153.2% | 加碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $1,943 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $1,784 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $1,633 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $1,520 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $1,476 萬 | 0.4% | +150,000+27.3% | 加碼 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $1,475 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $1,470 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $1,434 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $1,422 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $1,397 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $1,304 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $1,296 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $1,213 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $1,194 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 250,000 | $1,193 萬 | 0.4% | −100,000−28.6% | 減碼 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $1,188 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $1,130 萬 | 0.3% | 00.0% | 不變 | – |
| Exscientia PLC30223G102 | ADS | 550,000 | $1,087 萬 | 0.3% | +550,000 | 新進 | – |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $1,075 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 3,000,000 | $978.0 萬 | 0.3% | +1,000,000+50.0% | 加碼 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 750,000 | $964.5 萬 | 0.3% | +750,000 | 新進 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $877.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $870.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $856.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $821.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $810.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 1,000,000 | $806.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $802.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $800.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $770.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $755.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $746.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 450,000 | $737.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $732.8 萬 | 0.2% | 00.0% | 不變 | – |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $720.0 萬 | 0.2% | +450,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $684.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 700,000 | $669.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $648.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $639.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $624.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $619.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CRISCuris Inc | COM NEW | 1,300,000 | $618.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 405,347 | $611.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $607.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $599.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $594.3 萬 | 0.2% | +107,500+75.4% | 加碼 | – |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $588.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 1,200,000 | $553.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $541.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $528.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $525.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $523.5 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $496.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $495.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $493.0 萬 | 0.1% | 00.0% | 不變 | – |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $478.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 3 季之後清倉（8 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| XLRNAcceleron Pharma Inc | COM | 1,000,000 | $1.72 億 | 4.2% | 歷史 |
| BABAAlibaba Group Holding Ltd | ADR | 100,000 | $1,481 萬 | 0.4% | 歷史 |
| DRNADicerna Pharmaceuticals Inc | COM | 700,000 | $1,411 萬 | 0.3% | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $1,028 萬 | 0.3% | 歷史 |
| OLPXOlaplex Holdings, Inc. | COM | 225,000 | $551.3 萬 | 0.1% | 歷史 |
| AVTRAvantor, Inc. | COM | 50,000 | $204.5 萬 | 0.1% | 歷史 |
| OPTUOptimum Communications, Inc. | CL A | 27,000 | $55.9 萬 | <0.1% | 歷史 |
| EQTEQT Corp | Stock | 9,678 | $19.8 萬 | <0.1% | 歷史 |